Osteoclast-targeted therapy for metastatic prostate cancer

Author： Lee Richard J   Smith Matthew R  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.1, 2008-01, pp. : 63-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapy in the Treatment of Metastatic Renal Cell Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 122-131

Karger

Access to resources Recommend Favorite

Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy

By  

Urologia Internationalis, Vol. 99, Iss. 2, 2017-02 ,pp. : 125-136

Karger

Access to resources Recommend Favorite

Cabazitaxel for the therapy of metastatic castration‐resistant prostate cancer in the aftermath of the CHAARTED trial

By  

BJU INTERNATIONAL, Vol. 116, Iss. 6, 2015-12 ,pp. : 839-840

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of metastatic prostate cancer

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 4, 2015-07 ,pp. : 7-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 217-221

Karger

Access to resources Recommend Favorite